$12.060
-0.226 (-1.87%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
TRVI Prediction & Forecast by Similar Chart Analysis
Alphio's TRVI stock price prediction model matches the current Trevi Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $12.31 (+1.65%). The 1-week path is $12.55 (+3.63%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Trevi Therapeutics Inc Stock?
Trevi Therapeutics is a good buy right now due to its current price of $13.19, which is significantly below the analyst price targets ranging from $23 to $36. The company also has a strong cash position of approximately $319 million, ensuring operational stability and growth potential. However, the main risk is the negative earnings per share (EPS) of -0.11 reported for Q2 2026, indicating ongoing losses that investors should monitor closely.
TRVI stock price ended at $12.06 on Wednesday, after losing -1.87%
Trevi Therapeutics Inc (TRVI) last closed at $12.11, gaining +0.41%. These facts feed the 1-day and 1-week TRVI price prediction above.
Forecast Drivers
Trevi Therapeutics Inc (TRVI) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bearish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches TRVI, ranked by similarity.
Seasonality analysis for TRVI
Historically the probability of a positive October return for TRVI is 100.00%. May offers the highest probability of a positive month at 100.00%, while January is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for TRVI
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Oct 2026 | $6.23 | $6.86 | $7.76 | -43.37% |
| Nov 2026 | $5.82 | $6.12 | $7.19 | -49.44% |
| Dec 2026 | $5.27 | $6.52 | $7.16 | -46.12% |
In 2026, Trevi Therapeutics Inc (TRVI) is projected to range from $5.27 to $7.76.
Trevi Therapeutics Inc 2026 monthly forecast
In Oct 2026, Trevi Therapeutics Inc is projected to average $6.86, with a low of $6.23 and high of $7.76.
In Nov 2026, Trevi Therapeutics Inc is projected to average $6.12, with a low of $5.82 and high of $7.19.
In Dec 2026, Trevi Therapeutics Inc is projected to average $6.52, with a low of $5.27 and high of $7.16.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.